Inventor
HOLCOMB RYAN ERIK
US11 patents
⚠️ This page may combine multiple inventors who share the name “HOLCOMB RYAN ERIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE VIROPHARMA INC
5 patentsUS9616111B2Apr 11, 2017
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
SHIRE VIROPHARMA INC12 citations90
US10080788B2Sep 25, 2018
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
SHIRE VIROPHARMA INC4 citations82
US10201595B2Feb 12, 2019
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
SHIRE VIROPHARMA INC2 citations71
US10130690B2Nov 20, 2018
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
SHIRE VIROPHARMA INC2 citations71
US10105423B2Oct 23, 2018
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
SHIRE VIROPHARMA INC2 citations71
KINIKSA PHARMACEUTICALS LTD
3 patentsUS11141479B2Oct 12, 2021
Stable anti-OSMR antibody formulation
KINIKSA PHARMACEUTICALS LTD0 citations59
US10493149B2Dec 3, 2019
Stable anti-OSMR antibody formulation
KINIKSA PHARMACEUTICALS LTD0 citations47
US10391170B2Aug 27, 2019
Stable anti-OSMR antibody formulation
KINIKSA PHARMACEUTICALS LTD0 citations47
VIROPHARMA BIOLOGICS LLC
2 patentsUS11364288B2Jun 21, 2022
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
VIROPHARMA BIOLOGICS LLC1 citations69
US11534482B2Dec 27, 2022
C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency
VIROPHARMA BIOLOGICS LLC0 citations59